A detailed history of Virtu Financial LLC transactions in Orgenesis Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 12,112 shares of ORGS stock, worth $15,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,112
Holding current value
$15,745
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.39 - $0.63 $4,723 - $7,630
12,112 New
12,112 $7,000
Q2 2022

Aug 09, 2022

SELL
$1.8 - $3.74 $23,562 - $48,956
-13,090 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$2.31 - $3.72 $45,640 - $73,499
-19,758 Reduced 60.15%
13,090 $45,000
Q4 2021

Feb 17, 2022

BUY
$2.61 - $4.9 $85,733 - $160,955
32,848 New
32,848 $95,000
Q4 2020

Feb 24, 2021

SELL
$4.4 - $5.63 $53,020 - $67,841
-12,050 Closed
0 $0
Q3 2020

Dec 11, 2020

BUY
$4.75 - $5.99 $57,237 - $72,179
12,050 New
12,050 $61,000

Others Institutions Holding ORGS

About Orgenesis Inc.


  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $33.2M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.